Rocket Pharmaceuticals Statistics
NASDAQ: RCKTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.67+0.035 (+1.33%)
Market open · Delayed 15 min · as of Oct 9, 10:13 AM ET
Rocket Pharmaceuticals by the numbers
Rocket Pharmaceuticals has a market capitalization of $292.5 million based on 109.77M shares outstanding. With trailing EPS of $-0.17, Rocket Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.5% below its 50-day average and 25.0% below its 200-day average.
Average daily trading volume is 1.67M shares, or about $4.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RCKT valuation vs. peer median
| Metric | RCKT | Peer median | Difference |
|---|---|---|---|
| Market cap | $292.55M | $282.98M | +3% |
| Avg. volume | 1.67M | 1.12M | +49% |
Peer median across 8 companies: BIOA, FULC, ABEO, LRMR, BBOT, VNDA, BCYC, CATX.
Valuation
- Market cap
- $292.55M
- EPS (TTM)
- $-0.17
- Shares outstanding
- 109.77M
Price and trading
- Previous close
- 2.63
- Open
- 2.60
- Day range
- 2.54 – 2.69
- 52-week range
- 2.42 – 5.45
- 52-week change
- -22.42%
- Beta
- —
- Volume
- 483.54K
- Average volume
- 1.67M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 292.55M
- Forward Pe
- -2.05
- Eps
- -0.17
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.45
- Week52 Low
- 2.42
- Avg Volume
- 1.67M
- Shares Outstanding
- 109.77M
- Ma50
- 3.31
- Ma200
- 3.55
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -51.10%
- Pct From52w Low
- 10.12%